Related Experiment Video
Updated: May 1, 2026
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
[The shRNA-mediated downregulation of protein kinase D-2 enhanced chemosensitivity of Tca8113]
Objective:
To explore the effect of silencing protein kinase D (PKD)-2 on Tca8113 cell proliferation, programmed cell death, and chemosensitivity.
Methods:
The stable cell lines of pkd-2 gene silencing and empty vector plasmid group were established. The proliferation and 50% inhibitory concentration (IC50) of shRNA-mediated Tca8113 chemotherapy drugs were detected through methyl thiazolyl tetrazolium assay (MTT). The programmed cell death rate and sensitivity to Tca8113 chemotherapy drugs before or after pkd-2 gene silencing were measured through flow cytometry. P-glycoprotein (P-gp) expression of pkd-2 silencing cells was identified by immunohistochemical methods.
Results:
Stable cell lines of pkd-2 gene silencing were established. Compared with parental cells, the proliferation of shRNA-mediated Tca8113 was not significantly different, but its IC50 was lower. Meanwhile, cell programmed death rate and sensitivity to chemotherapeutic drugs of shRNA-mediated Tca8113 significantly increased. Compared with wild group Tca8113, a significant decrease in P-gp expression was induced by chemotherapy drugs with shRNA-pkd-2 gene silencing.
Conclusion:
The pkd-2 gene of shRNA interference silencing Tca8113 promotes programmed cell death of Tca8113, reduces the IC50 of the chemotherapy drugs, and significantly improves the sensitivity of Tca8113 to chemotherapeutic drugs while reducing the expression of P-gp.
Insights
Silencing the protein kinase D (PKD)-2 gene in Tca8113 cells enhances their sensitivity to chemotherapy drugs. This approach promotes programmed cell death and reduces P-glycoprotein expression, improving treatment efficacy.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Protein kinase D (PKD)-2 plays a role in cellular processes.
- Understanding its function in cancer cells is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the impact of silencing the PKD-2 gene on Tca8113 cell proliferation, programmed cell death, and chemosensitivity.
Main Methods:
- Established stable cell lines with PKD-2 gene silencing using shRNA.
- Assessed cell proliferation and drug sensitivity (IC50) via MTT assay.
- Measured programmed cell death and drug sensitivity using flow cytometry.
- Identified P-glycoprotein (P-gp) expression through immunohistochemistry.
Main Results:
- PKD-2 gene silencing did not significantly alter Tca8113 cell proliferation but lowered the IC50 for chemotherapy drugs.
- Significant increases in programmed cell death rate and drug sensitivity were observed.
- Reduced P-gp expression was noted in cells with silenced PKD-2 gene.
Conclusions:
- Silencing the PKD-2 gene in Tca8113 cells promotes programmed cell death.
- This silencing reduces chemotherapy drug IC50 and significantly enhances drug sensitivity.
- Reduced P-gp expression is a key outcome of PKD-2 gene silencing.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Related Concept Videos
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
02:34Inhibition of CDK Activity
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...